These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31994746)

  • 1. Dental management of a child with Wiskott Aldrich syndrome prior to bone marrow transplant: A case report.
    Santosh A; Banthiya K; Deshmukh CT; Bhange P; Shah S; Kakade A
    Spec Care Dentist; 2020 Mar; 40(2):206-210. PubMed ID: 31994746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
    Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome.
    Meuwissen HJ; Bortin MM; Bach FH; Porter IH; Schreinmachers D; Harrison BA; Taft E
    J Pediatr; 1984 Sep; 105(3):365-9. PubMed ID: 6381679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
    Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
    Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
    Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of a patient with Wiskott-Aldrich syndrome using hematopoietic stem cell transplantation--case report and literature review].
    Yu J; Guan XM; Dai BT; Jiang LP; Su YC; Xiao JW; Liu XM; Xian Y; Xu YH; Yang XQ; Zhao XD
    Zhonghua Er Ke Za Zhi; 2009 Mar; 47(3):183-8. PubMed ID: 19573431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.
    Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
    Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful allogeneic peripheral blood stem cell transplantation in Wiskott-Aldrich Syndrome Patients: first report in Thailand.
    Hongeng S; Benjaponpitak S; Tardtong P; Varavithya W; Chuansumrit A; Chunharas A; Chaisiripoomkere W; Hathira P
    Asian Pac J Allergy Immunol; 2001 Sep; 19(3):191-5. PubMed ID: 11826914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
    N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Reduced Intensity Conditioning Alternate Donor Stem Cell Transplant for Wiskott-Aldrich Syndrome.
    Thakkar D; Katewa S; Rastogi N; Kohli S; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e493-e496. PubMed ID: 28859032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Maldonado MS; Muñoz A; Otheo de Tejada E; Roldán E; Aymerich L; Brieva JA
    Med Clin (Barc); 1993 Sep; 101(7):258-60. PubMed ID: 7746001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
    Loyola Presa JG; de Carvalho VO; Morrisey LR; Bonfim CM; Abagge KT; Vasselai A; Marinoni LP
    Arch Dis Child; 2013 Apr; 98(4):304-7. PubMed ID: 23343520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago.
    Lang P; Klingebiel T; Schumm M; Handgretinger R; Greil J; Beck JF; Niethammer D; Bader P
    Bone Marrow Transplant; 2004 Apr; 33(8):879-80. PubMed ID: 14743191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.